Francis Sarena - Apexigen Chief Officer
| APGNDelisted Stock | USD 0.43 0.01 2.27% |
Insider
Francis Sarena is Chief Officer of Apexigen
| Age | 52 |
| Phone | 650-931-6236 |
| Web | https://www.apexigen.com |
Apexigen Management Efficiency
The company has return on total asset (ROA) of (0.894) % which means that it has lost $0.894 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.9805) %, meaning that it created substantial loss on money invested by shareholders. Apexigen's management efficiency ratios could be used to measure how well Apexigen manages its routine affairs as well as how well it operates its assets and liabilities.Apexigen currently holds 106 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Apexigen has a current ratio of 1.22, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Apexigen's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard MD | X4 Pharmaceuticals | 61 | |
| Renato Skerlj | X4 Pharmaceuticals | N/A | |
| Ibrahim MD | Enveric Biosciences | 55 | |
| Avani Kanubaddi | Enveric Biosciences | 51 | |
| Nandan BS | Immix Biopharma | 62 | |
| Mary DiBiase | X4 Pharmaceuticals | 63 | |
| Murray MD | X4 Pharmaceuticals | 63 | |
| Walter Newman | Leap Therapeutics | 78 | |
| DSc MSE | Immix Biopharma | 75 | |
| Peter Facchini | Enveric Biosciences | 60 | |
| Dr MedSc | Phio Pharmaceuticals Corp | 68 | |
| Arthur Taveras | X4 Pharmaceuticals | 60 | |
| Keith MD | X4 Pharmaceuticals | 53 | |
| Christine Granfield | Leap Therapeutics | 56 | |
| Augustine Lawlor | Leap Therapeutics | 67 | |
| JD MBA | Immix Biopharma | N/A | |
| Gabriel BA | Immix Biopharma | 37 | |
| Joseph Tucker | Enveric Biosciences | 55 | |
| Mark OMahony | Leap Therapeutics | 53 | |
| MBA IV | Enveric Biosciences | 68 | |
| Cynthia Sirard | Leap Therapeutics | 54 | |
Management Performance
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 |
Apexigen Leadership Team
Elected by the shareholders, the Apexigen's board of directors comprises two types of representatives: Apexigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apexigen. The board's role is to monitor Apexigen's management team and ensure that shareholders' interests are well served. Apexigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apexigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaodong MD, CEO Pres | ||
| Francis Sarena, Chief Officer | ||
| Frank MD, Chief Officer | ||
| William Duke, Chief Officer | ||
| Jason Wright, VP CMC | ||
| Amy Wong, Sr Operations |
Apexigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apexigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 | |||
| Current Valuation | 205.33 K | |||
| Shares Outstanding | 24.86 M | |||
| Shares Owned By Insiders | 8.81 % | |||
| Shares Owned By Institutions | 13.54 % | |||
| Number Of Shares Shorted | 64.45 K | |||
| Price To Book | 2.32 X | |||
| EBITDA | (32.58 M) | |||
| Net Income | (32.07 M) |
Pair Trading with Apexigen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apexigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will appreciate offsetting losses from the drop in the long position's value.Moving against Apexigen Stock
The ability to find closely correlated positions to Apexigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apexigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apexigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apexigen to buy it.
The correlation of Apexigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apexigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apexigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apexigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |